News

CPhA is pleased with the announcement from the Federal Minister of Health, Honourable Ginette Petitpas Taylor, that Health Canada will ease access to opioid substitution treatments methadone and diacetylmorphine.

March is Pharmacist Awareness Month in Canada, a month long period to celebrate the contributions that pharmacists make to our health care system.

CPhA is pleased that the 2018 federal budget commits to looking at pharmacare options through the establishment of an Advisory Council on the Implementation of National Pharmacare.

The evidence guide provides pharmacists and other health care providers with a curated summary of the best available evidence of the use of medical cannabis and cannabinoids for a variety of indications.

New pan-Canadian Pharmaceutical Alliance agreement an opportunity to increase the accessibility of quality healthcare services for patients.

New working group tasked with defining and developing a forward-thinking, uniformed national scope of practice for the pharmacy profession.

The Board is pleased to announce that Glen Doucet, current CPhA Vice-President of Public and Professional Affairs, will assume the role of Interim CEO.

Pharmacists in every community across the country are gravely concerned about the increased rates of opioid-related deaths and stand shoulder-to-shoulder with all governments and stakeholders in identifying solutions that will help prevent misuse of opioids, provide greater access to harm reduction tools and services, and support use of addiction management therapies.